Nitric Oxide

一氧化氮

Report date: 2026/03/19 20:00:18

Base Information

Drug NameNitric Oxide
Drug Alias NameINOMAXNONSKINOX
ClassificationSmall molecules
Mechanisms of ActionNitric oxide donors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Heart DiseasesBrain Injuries, Traumatic +[10] 
Global Approved IndicationsRespiratory InsufficiencyPulmonary Arterial HypertensionHypertension, Pulmonary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/12/23
Country/TerritoryCanadaUnited StatesRussian Federation +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesIno Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Seika Chemicals Co LtdResearch Institute for Complex Issues of Cardiovascular Diseases, KemerovoBeyond Air Inc +[9] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Heart DiseasesBrain Injuries, Traumatic +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A